Griffin Asset Management, Inc. Pulse Biosciences, Inc. Transaction History

Griffin Asset Management, Inc.

$879 Million
Q3 2024

A detailed history of Griffin Asset Management, Inc. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 257,449 shares of PLSE stock, worth $3.75 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

257,449

Previous 257,679 0.09%

Holding current value

$3.75 Million

Previous $2.88 Million 56.61%

% of portfolio

0.51%

Previous 0.34%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$10.83 - $21.83 $2,490 - $5,020	-230 Reduced 0.09%	257,449 $4.52 Million
Q2 2024 Jul 23, 2024	SELL	$6.69 - $14.54 $285,268 - $620,000	-42,641 Reduced 14.2%	257,679 $2.88 Million
Q1 2024 Apr 17, 2024	BUY	$7.8 - $11.02 $317,460 - $448,514	40,700 Added 15.68%	300,320 $2.62 Million
Q4 2023 Jan 19, 2024	SELL	$3.85 - $12.84 $58,289 - $194,397	-15,140 Reduced 5.51%	259,620 $3.18 Million
Q3 2023 Oct 19, 2023	BUY	$4.03 - $8.73 $324,052 - $701,979	80,410 Added 41.37%	274,760 $1.11 Million
Q2 2023 Aug 01, 2023	BUY	$3.67 - $8.64 $91,750 - $216,000	25,000 Added 14.76%	194,350 $1.4 Million
Q1 2023 May 09, 2023	SELL	$2.48 - $3.88 $16,226 - $25,386	-6,543 Reduced 3.72%	169,350 $569,000
Q4 2022 Jan 20, 2023	BUY	$1.73 - $2.89 $155,802 - $260,270	90,059 Added 104.92%	175,893 $0
Q3 2022 Oct 19, 2022	BUY	$1.23 - $2.3 $21,381 - $39,980	17,383 Added 25.39%	85,834 $197,000
Q2 2022 Jul 19, 2022	SELL	$1.48 - $4.28 $9,472 - $27,392	-6,400 Reduced 8.55%	68,451 $105,000
Q1 2022 Apr 12, 2022	SELL	$4.21 - $14.79 $4,664 - $16,387	-1,108 Reduced 1.46%	74,851 $364,000
Q4 2021 Jan 28, 2022	BUY	$14.78 - $24.4 $214,132 - $353,507	14,488 Added 23.57%	75,959 $1.13 Million
Q3 2021 Nov 05, 2021	BUY	$17.25 - $26.63 $51,750 - $79,890	3,000 Added 5.13%	61,471 $1.33 Million
Q1 2021 May 04, 2021	SELL	$22.43 - $44.27 $634,948 - $1.25 Million	-28,308 Reduced 32.62%	58,471 $1.39 Million
Q4 2020 Jan 27, 2021	BUY	$11.66 - $24.5 $215,744 - $453,323	18,503 Added 27.1%	86,779 $2.07 Million
Q3 2020 Nov 12, 2020	BUY	$9.27 - $13.14 $245,210 - $347,579	26,452 Added 63.25%	68,276 $805,000
Q2 2020 Aug 18, 2020	SELL	$6.23 - $13.09 $7,451 - $15,655	-1,196 Reduced 2.78%	41,824 $437,000
Q1 2020 May 18, 2020	SELL	$5.23 - $15.2 $35,380 - $102,828	-6,765 Reduced 13.59%	43,020 $308,000
Q4 2019 Feb 11, 2020	BUY	$12.58 - $15.97 $22,015 - $27,947	1,750 Added 3.64%	49,785 $668,000
Q3 2019 Nov 05, 2019	SELL	$10.73 - $17.33 $99,574 - $160,822	-9,280 Reduced 16.19%	48,035 $742,000
Q2 2019 Aug 19, 2019	BUY	$11.11 - $17.34 $66,160 - $103,259	5,955 Added 11.59%	57,315 $757,000
Q1 2019 May 08, 2019	BUY	$11.69 - $19.44 $600,398 - $998,438	51,360 New	51,360 $903,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.8M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Pulse Biosciences, Inc. Transaction History